10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)

10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)

Catheter ablation is the definitive curative therapy for a wide spectrum of cardiac tachyarrhythmias. Achieving successful, durable transmural electrical isolation while avoiding catastrophic collateral injury requires an understanding of energy-tissue interactions.

Modern electrophysiology encompasses three fundamentally distinct biophysical energy modalities:

1. Radiofrequency (RF) Energy: Thermal hyperthermic injury mediated by unmodulated alternating electrical current.
2. Cryoablation: Thermal hypothermic injury mediated by cryogenic phase changes and tissue freezing.
3. Pulsed Field Ablation (PFA): Non-thermal cellular death mediated by irreversible electroporation (IRE) of the cellular lipid bilayer.

---

Radiofrequency (RF) Biophysics & Thermal Myocardial Injury

Radiofrequency catheter ablation utilizes an ungrounded alternating electrical current oscillating at radio frequencies—standardly between 350 kHz and 500 kHz (typically 480 to 500 kHz).

+-----------------------------------------------------------------------------------------+
|                        RADIOFREQUENCY (RF) HEATING PROFILE                              |
+-----------------------------------------------------------------------------------------+
| Catheter Tip (Irrigated Saline Flush: 15-30 mL/min keeps tip < 40-50 deg C)             |
|      |                                                                                  |
| [1-2 mm Direct Contact]: RESISTIVE HEATING ZONE (Current density J = I/A is highest)     |
|      |                                                                                  |
| [2-8 mm Deeper Layers]: CONDUCTIVE HEATING ZONE (Passive thermal conduction transfer)   |
|      |                                                                                  |
| Irreversible Necrosis Threshold: >= 50 deg C                                            |
| Subsurface Water Boiling & Steam Pop Threshold: > 100 deg C                             |
+-----------------------------------------------------------------------------------------+

The Mechanism of RF Heating: Resistive vs. Conductive Zones

At 500 kHz, electrical polarity reverses 500,000 times per second. This rapid oscillation is far too fast to cause conformational opening of voltage-gated sodium channels, preventing myocardial depolarization, extrasystoles, or ventricular fibrillation. Instead, the alternating electrical field drives rapid physical agitation of intracellular and extracellular ions ($Na^+$, $K^+$, $Cl^-$). As these ions oscillate, friction generates heat—a process governed by Joule's Law:

$Q = I^2 \times R \times t$

Where $Q$ is heat generated, $I$ is delivered current, $R$ is tissue electrical resistance, and $t$ is application duration.

Tissue heating develops across two distinct zones:

1. Direct Resistive Heating Zone: Occurs strictly in the immediate tissue layer in direct physical contact with the catheter electrode, extending to a depth of only 1 to 2 mm. Current density ($J = I / A$) is highest at the small metallic electrode surface and dissipates exponentially with the fourth power of distance ($1/r^4$). Consequently, true resistive electrical heating is confined to the immediate superficial rim of tissue.
2. Indirect Conductive Heating Zone: Tissue situated deeper than 2 mm receives virtually no direct electrical resistive heating. Instead, deeper myocardial layers (extending up to 6 to 8 mm depth) are heated purely by passive thermal conduction transferred inward from the superficial resistive zone. The ultimate depth of the lesion depends on thermal tissue conductivity, contact force, blood flow convective cooling, and application duration.

Temperature Thresholds of Cellular Thermal Injury

Myocardial response to hyperthermia follows distinct biophysical thresholds:

• $37^\circ\text{C}$ (Normal Body Temperature): Baseline physiological function.
• $42^\circ\text{C to }49^\circ\text{C}$ (Reversible Dysfunction): Membrane fluidity increases, ion channel kinetics slow, and conduction slows or blocks. Tissue rewarming restores complete normal electrical and mechanical function.
• $\ge 50^\circ\text{C}$ (Irreversible Coagulative Necrosis): Critical therapeutic threshold. At $50^\circ\text{C}$ maintained for several seconds, irreversible protein denaturation occurs: cellular enzymes inactivate, cell membrane lipid bilayers rupture, structural contractile proteins coagulate, and microvascular thrombosis ensues, culminating in permanent coagulative necrosis and circumscribed fibrous scar.
• $> 100^\circ\text{C}$ (Vaporization, Boiling & Steam Pops): When intramural tissue temperature reaches $100^\circ\text{C}$, interstitial water within myocardial cells boils and converts to pressurized, superheated steam.

Pathophysiology of "Steam Pops" and Coagulum

• Steam Pop Explosion: If tissue heating is excessive, subsurface steam cannot vent through the compressed, coagulated endocardial surface. When interstitial steam pressure exceeds the mechanical tensile strength of the myocardium, the tissue ruptures violently. This steam pop produces an audible "pop" in the EP suite, tears myocardial fibers, blows out an irregular intramural crater, and risks catastrophic cardiac wall perforation, acute hemopericardium, and cardiac tamponade.
• Surface Char and Thrombus Formation: When the blood-electrode interface exceeds $80^\circ\text{C}$, plasma proteins (particularly albumin and fibrinogen) denature and aggregate, forming a sticky, dense, non-conductive char / coagulum on the electrode tip. This insulates the electrode, causing an immediate, precipitous rise in circuit electrical impedance and creating a potent source for systemic thromboembolism (stroke).

---

RF Catheter Technologies: Open-Irrigation, Contact Force & Lesion Metrics

Delivering adequate thermal energy to create deep, transmural lesions without causing surface char or steam pops led to critical engineering advancements.

Non-Irrigated vs. Open-Irrigated Catheters

• Non-Irrigated (Solid Tip) Catheters: Rely solely on ambient intracardiac blood flow to cool the electrode. At sites of low blood flow (e.g., within deep trabeculations, coronary sinus, or ventricular scar pouches), the electrode-blood interface heats rapidly. To prevent charring at $80^\circ\text{C}$, the RF generator automatically throttles power down to low levels (e.g., 15 to 25 W). As a result, non-irrigated catheters produce shallow lesions (typically 2 to 3 mm depth), frequently failing to achieve transmural block.
• Open-Irrigated Catheters (Clinical Standard): Feature hollow tips perforated with 6 to 56 microscopic irrigation pores. Room-temperature or chilled heparinized normal saline is continuously pumped through the tip:
  • Standby Flow: 2 mL/min during intracardiac manipulation to prevent blood from entering and clotting within the micro-pores.
  • Ablation Flow: 15 to 30 mL/min (typically 17 to 20 mL/min for power $\le 30\text{ W}$, 30 mL/min for power $> 30\text{ W}$) initiated automatically 2 seconds prior to RF delivery.
• Biophysical Effect of Open Irrigation:
  1. Active saline cooling keeps the electrode surface and surrounding blood pool cool (typically $<40^\circ\text{ to }50^\circ\text{C}$), completely preventing surface protein denaturation, char, and coagulum.
  2. Because surface temperature limits are never breached, the generator can safely deliver sustained higher power (35 to 50 Watts).
  3. High power drives deeper resistive heating, which shifts the peak tissue temperature several millimeters below the endocardial surface, creating significantly deeper, wider, and durable transmural lesions.
• Critical Clinical Caveat: With open-irrigated catheters, the thermocouple inside the catheter tip measures the temperature of the cooling saline, not the tissue temperature. The operator cannot rely on temperature feedback and must monitor power, duration, impedance drop, and contact force.

Contact Force (CF) Sensing Mechanics

Catheter-to-tissue contact force is the single most critical determinant of lesion size during RF ablation. Modern catheters incorporate either triaxial optical fiber interferometry (Carto SmartTouch) or deformable magnetic spring coil sensors (TactiCath) in the distal shaft to measure instantaneous contact force in grams ($g$).

• Optimal Clinical Target Range: 10 to 20 grams (acceptable working window 10 to 25 g).
• Insufficient Contact Force (< 5 g):
  • Poor mechanical coupling causes delivered RF current to dissipate harmlessly into the circulating blood pool (blood pool washing).
  • Tissue heating is minimal, resulting in superficial, ineffective lesions and high rates of clinical arrhythmia recurrence.
• Excessive Contact Force (> 30 to 40 g):
  • Compresses myocardial tissue, significantly reducing local capillary perfusion and impairing convective heat dissipation.
  • Drives subsurface tissue temperatures above $100^\circ\text{C}$, dramatically increasing the risk of explosive steam pops and mechanical chamber perforation.

Lesion Index Metrics: Ablation Index (AI) and Lesion Size Index (LSI)

Because lesion dimensions depend non-linearly on the combination of power, time, and contact force, modern EAM systems incorporate predictive lesion synthesis algorithms:

• Ablation Index (AI - Biosense Webster): A proprietary non-linear mathematical formula that integrates contact force, RF duration, and power delivery:

$\text{AI} = \left[ \int_0^t \text{CF}(t)^a \times \text{Power}(t)^b \, dt \right]^c$

Where exponents $a$, $b$, and $c$ weight the biological impact of each variable. Clinical target AI values are tailored to anatomical wall thickness:

• Posterior Left Atrial Wall (Thin wall, adjacent to esophagus): Target AI 380 to 400 (contact force 10-15 g, power 25-35 W, application duration 15-20 s).
• Anterior / Roof Left Atrial Wall & CTI (Thick tissue): Target AI 450 to 550 (contact force 15-20 g, power 40-50 W, application duration 25-35 s).
• Lesion Size Index (LSI - Abbott): Integrates contact force, RF time, power, and real-time impedance drop. Clinical target LSI values typically range from 5.0 to 6.0 for atrial wall ablation.

Impedance Drop Dynamics

Circuit electrical impedance (typically 90 to 140 $\Omega$ at baseline) reflects the total resistance of the RF circuit (catheter tip, myocardial tissue, thorax, and dispersive grounding pad):

• Normal Therapeutic Response: As myocardial tissue heats up, cellular membranes permeabilize and ion mobility increases, causing electrical resistance to drop. An impedance drop of 5 to 15 $\Omega$ (typically 8 to 12 $\Omega$) during the first 10 to 20 seconds of RF delivery confirms effective tissue heating and lesion formation.
• Dangerous Impedance Rise (> 10 to 20 $\Omega$ Spike): A sudden, sharp impedance increase indicates that tissue boiling has occurred or that non-conductive coagulum/char has coated the electrode. The RF generator must abort delivery immediately to prevent an impending steam pop.

---

Cryoablation Biophysics: Hypothermic Injury & Cryomapping

Cryoablation destroys arrhythmogenic myocardium by extracting heat, inducing controlled, circumscribed cellular freezing.

The Joule-Thomson Effect & Nitrous Oxide Delivery

Cryoablation systems (e.g., Arctic Front Advance cryoballoon, Freezor MAX focal catheter) utilize liquid nitrous oxide ($N_2O$) stored under high pressure (~600 to 750 psi) in a central console.

• Liquid $N_2O$ is pumped through ultra-fine vacuum-insulated capillary tubing into the inner lumen of the catheter tip or balloon.
• Upon entering the tip chamber, the liquid undergoes sudden, rapid expansion through a micro-orifice into a low-pressure gas environment. According to the Joule-Thomson effect, the rapid adiabatic expansion of a real gas causes an immediate, dramatic drop in temperature, cooling the inner chamber down to $-80^\circ\text{C}$ to $-89^\circ\text{C}$.
• The expanding gas absorbs heat directly from adjacent cardiac tissue across the metallic catheter shell before being vacuum-scavenged back to the console.

Phases of Cryothermal Tissue Destruction

Cryoablation injures tissue through four sequential biophysical mechanisms:

1. Freeze / Ice Crystal Phase: Extracellular water freezes first, forming ice crystals. Because ice exclude solutes, the remaining extracellular fluid turns hyperosmotic, drawing water out of myocardial cells and causing severe hyperosmotic cellular dehydration. During rapid freezing to temperatures below $-40^\circ\text{C}$, destructive intracellular ice crystals form, physically shearing organelle membranes and the sarcolemma.
2. Thaw Phase (Critical Destructive Period): As tissue rewarms, small ice crystals fuse into large, jagged crystalline conglomerates before melting. Hypotonic extracellular fluid rushes back into dehydrated, membrane-damaged cells, causing rapid cellular swelling, lysis, and membrane rupture. Slow, unassisted thawing produces significantly greater cellular destruction than rapid rewarming.
3. Vascular Stasis & Ischemia: Over the subsequent hours, microvascular endothelial injury triggers platelet aggregation, capillary thrombosis, and microcirculatory shutdown, causing secondary ischemic coagulative infarction of the frozen zone.
4. Apoptosis & Dense Fibrotic Scar: Cells surviving the acute freeze-thaw transition undergo programmed cell death (apoptosis) over days, resulting in a dense, sharply demarcated fibrous scar with minimal inflammatory exudate.

Cryomapping vs. Cryoablation Protocols

Cryoenergy provides an invaluable clinical safety feature: the ability to test target sites reversibly before committing to permanent tissue destruction.

• Cryomapping ($-30^\circ\text{C}$): The catheter cools the target tissue to $-30^\circ\text{C}$ to $-35^\circ\text{C}$ for up to 60 to 80 seconds. At this moderate hypothermic level, cellular enzymatic activity and membrane conduction are reversibly stunned, but cell membranes remain structurally intact. If the arrhythmia terminates (e.g., slow pathway conduction blocks or accessory pathway conduction ceases), the site is confirmed. Crucially, if undesirable collateral injury occurs—such as prolongation of the PR interval or transient complete AV block—ablation is immediately aborted; the tissue rewarms, and normal conduction recovers completely without permanent injury.
• Cryoablation ($-80^\circ\text{C}$): Once safety and efficacy are confirmed during cryomapping, full cryoenergy is engaged, driving temperatures down to $-70^\circ\text{C}$ to $-80^\circ\text{C}$ for 180 to 240 seconds, producing permanent, irreversible transmural coagulative necrosis.

Cryoballoon Technology for Pulmonary Vein Isolation (PVI)

• Anatomical Fit: Utilizes a non-compliant balloon (standardly 28-mm diameter) inflated at the antrum of each pulmonary vein.
• Vascular Occlusion Verification: Complete circumferential antral seal is confirmed via contrast injection under fluoroscopy (demonstrating total contrast retention without back-leak into the left atrium) or by disappearance of continuous pressure waveforms on the console.
• Phrenic Nerve Protection: During cryoballoon ablation of the right superior and right inferior pulmonary veins, the right phrenic nerve (which courses directly along the anterolateral aspects of these veins) is at high risk of thermal injury. The specialist continuously paces the right phrenic nerve from the superior vena cava at high output (e.g., 20 mA at 1.0 ms) while continuously monitoring diaphragmatic contraction via abdominal palpation or diaphragmatic electromyography (CMAP). At the earliest sign of diminished diaphragmatic movement, freezing is aborted immediately with rapid double-stop active deflation.

---

Pulsed Field Ablation (PFA): Non-Thermal Irreversible Electroporation

Pulsed Field Ablation (PFA) represents a revolutionary paradigm shift in catheter ablation. Unlike RF and cryoablation, which destroy tissue through thermal hyperthermia or hypothermia, PFA is a non-thermal energy modality that destroys cells via irreversible electroporation (IRE).

+-----------------------------------------------------------------------------------------+
|                        PULSED FIELD ABLATION (PFA) MECHANICS                            |
+-----------------------------------------------------------------------------------------+
| Ultra-Rapid High-Voltage Pulses (1,000 - 2,000 Volts in microsecond / nanosecond trains) |
|      |                                                                                  |
| Destabilizes Transmembrane Potential (Exceeds critical threshold > 500-1000 mV)         |
|      |                                                                                  |
| Nanoscale Aqueous Pores Form in Phospholipid Bilayer (Irreversible Electroporation)     |
|      |                                                                                  |
| Loss of Homeostasis -> Calcium Influx -> Mitochondrial Breakdown -> Apoptosis / Lysis   |
|      |                                                                                  |
| TISSUE SELECTIVITY ADVANTAGE:                                                           |
| Myocytes (~400 V/cm) << Nerves & Esophagus (>1,000-1,500 V/cm)                          |
+-----------------------------------------------------------------------------------------+

Biophysics of Irreversible Electroporation (IRE)

Under baseline conditions, living cardiac myocytes maintain a resting transmembrane potential ($V_m$) of approximately $-80\text{ to }-90\text{ mV}$ across the 5-nanometer lipid bilayer, maintaining an enormous resting electric field strength of approximately $10^5\text{ V/cm}$.

• When an intense, external pulsed electrical field (typically 1,000 to 2,000 Volts delivered as a train of biphasic microsecond or nanosecond pulses) is applied across myocardial tissue, it alters the transmembrane potential according to the Schwan equation:

$\Delta V_m = 1.5 \times r \times E \times \cos(\theta)$

Where $r$ is cell radius, $E$ is external electric field strength, and $\theta$ is the angle relative to the field vector.

• Pore Formation: When the induced transmembrane potential exceeds a critical threshold (typically 500 to 1,000 mV), the mechanical dielectric strength of the membrane is overwhelmed. Water molecules enter the hydrophobic core of the bilayer, creating hydrophilic nanoscale aqueous pores.
• Irreversible Pore Genesis: In PFA, the magnitude and repetition rate of the pulses ensure that the nanoscale pores cannot reseal. The cell membrane becomes permanently permeabilized, causing:
  1. Immediate, catastrophic collapse of electrical and chemical gradients.
  2. Massive, uncontrolled influx of extracellular calcium ($Ca^{2+}$).
  3. Rapid depletion of intracellular ATP as ion pumps attempt futilely to restore homeostasis.
  4. Mitochondrial swelling, outer membrane permeabilization, and cytochrome c release, triggering non-inflammatory cell death predominantly through apoptosis and rapid necrotic lysis.

The Defining Clinical Advantage: Myocardial Tissue Selectivity

The fundamental clinical advantage of PFA is tissue selectivity. Different biological cell types exhibit distinct electric field thresholds for irreversible electroporation:

• Ventricular & Atrial Myocytes: Large, elongated cells with high membrane capacitance. They possess the lowest electroporation threshold of any biological tissue (~400 to 500 V/cm), making them exceptionally sensitive to pulsed electrical fields.
• Vascular Smooth Muscle & Endothelium: Intermediate threshold.
• Esophageal Epithelium, Adventitia & Neurons (Phrenic, Vagus): Possess significantly smaller cell diameters, dense connective tissue architecture, and thick protective myelin sheaths. Their irreversible electroporation threshold is substantially higher (> 1,000 to 1,500 V/cm).

Clinical Impact of Tissue Selectivity

Because therapeutic PFA dosing protocols are calibrated to deliver field strengths of 600 to 900 V/cm across the atrial myocardium, the energy safely achieves complete transmural myocardial necrosis while sparing adjacent collateral structures:

• Esophageal Protection: Virtually eliminates the lethal complication of atrio-esophageal fistula, which plagues thermal RF and cryoablation.
• Nerve Protection: Spares the right phrenic nerve and periesophageal vagal plexus, dramatically reducing post-ablation gastroparesis and permanent diaphragmatic paralysis.
• Vascular Protection: Spares pulmonary vein elastic architecture, eliminating pulmonary vein stenosis.

Commercial PFA Platforms

Modern FDA-approved PFA platforms include:

• Farapulse (Boston Scientific): Features the Farawave catheter—a 5-spline variable-geometry catheter that transitions between a "basket" configuration (for pulmonary vein ostial seating) and a "flower" configuration (for wide antral ablation). Delivers 2-second biphasic high-voltage pulse trains (~1,800 to 2,000 V).
• PulseSelect (Medtronic): A circular 9-electrode catheter that delivers biphasic, microsecond pulsed electric fields for circumferential pulmonary vein isolation.

---

Comparative Analysis of Ablation Modalities